CAGW Submits Comments to FDA on Drug Importation Proposed Rule | Citizens Against Government Waste

CAGW Submits Comments to FDA on Drug Importation Proposed Rule

Agency Comments

March 5, 2020

 
Food and Drug Administration
Dockets Management Staff (HFA-305)
5630 Fishers Lane, Rm. 1061,
Rockville, Md. 20852

Docket No. FDA-2019-N-5711

Proposed Rule: Importation of Prescription Drugs

Background

Citizens Against Government Waste (CAGW) is a private, nonpartisan, nonprofit organization representing more than one million members and supporters nationwide.  CAGW's mission is to eliminate waste, mismanagement, and inefficiency in the federal government.  CAGW was founded in 1984 by the late industrialist J. Peter Grace and syndicated columnist Jack Anderson to implement the recommendations of President Ronald Reagan’s Private Sector Survey on Cost Control, also known as the Grace Commission.

Comment

Since 2000, the Food and Drug Administration (FDA) has refused to certify the safety of imported drugs for many good reasons.  Nothing has changed in 20 years that would reverse that original assessment and CAGW provides in our attached comment why importation of drugs from Canada should not be allowed.

Sincerely,

Thomas Schatz

President
CAGW

 

The PDF of the entire comment can be found here

Issues Topics: